These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12498003)

  • 1. Role of tumor necrosis factor in Crohn's disease.
    Ganesan S; Travis SP; Ahmad T; Jazrawi R
    Curr Opin Investig Drugs; 2002 Sep; 3(9):1297-300. PubMed ID: 12498003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
    Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic inhibitors of tumor necrosis factor in Crohn's disease.
    Ganesan S; Travis SP; Ahmad T; Jazrawi R
    Curr Opin Investig Drugs; 2002 Sep; 3(9):1301-6. PubMed ID: 12498004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumour necrosis factor alpha antibody treatment.
    Zeissig S; Bojarski C; Buergel N; Mankertz J; Zeitz M; Fromm M; Schulzke JD
    Gut; 2004 Sep; 53(9):1295-302. PubMed ID: 15306588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease.
    Schinzari F; Armuzzi A; De Pascalis B; Mores N; Tesauro M; Melina D; Cardillo C
    Clin Pharmacol Ther; 2008 Jan; 83(1):70-6. PubMed ID: 17507924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between tumor necrosis factor-alpha and Fc-gamma receptor polymorphisms with infliximab in Crohn's disease.
    Tomita K; Chiba T; Sugai T; Habano W
    Hepatogastroenterology; 2010; 57(99-100):535-9. PubMed ID: 20698223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of TNF-alpha/LTA polymorphisms with Crohn's disease in Koreans.
    Yang SK; Lee SG; Cho YK; Lim J; Lee I; Song K
    Cytokine; 2006 Jul; 35(1-2):13-20. PubMed ID: 16931032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of tumor necrosis factor in health and disease.
    Beutler BA
    J Rheumatol Suppl; 1999 May; 57():16-21. PubMed ID: 10328138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do anti-tumor necrosis factors induce response and remission in patients with acute refractory Crohn's disease? A systematic meta-analysis of controlled clinical trials.
    Rahimi R; Nikfar S; Abdollahi M
    Biomed Pharmacother; 2007 Jan; 61(1):75-80. PubMed ID: 17184965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor receptor gene polymorphisms in Crohn's disease: association with clinical phenotypes.
    Waschke KA; Villani AC; Vermeire S; Dufresne L; Chen TC; Bitton A; Cohen A; Thomson AB; Wild GE
    Am J Gastroenterol; 2005 May; 100(5):1126-33. PubMed ID: 15842589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis: polymorphisms in TNF-alpha gene promoter and Crohn's disease.
    Han Z; Li C; Han S; Han Y; Qiu J; Shi Y; Wang J; Sun A; Ding J; Wu K; Fan D
    Aliment Pharmacol Ther; 2010 Jul; 32(2):159-70. PubMed ID: 20456305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor-alpha haplotype is strongly associated with bone mineral density in patients with Crohn's disease.
    Lee N; Fowler E; Mason S; Lincoln D; Taaffe DR; Radford-Smith G
    J Gastroenterol Hepatol; 2007 Jun; 22(6):913-9. PubMed ID: 17565648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of linkage between lymphotoxin alpha haplotype and polymorphisms in 5'-flanking region of tumor necrosis factor alpha gene associated with efficacy of infliximab for Crohn's disease patients.
    Ozeki T; Furuya Y; Nagano C; Matsui C; Takayanagi R; Yokoyama H; Yamada Y
    Mutat Res; 2006 Dec; 602(1-2):170-4. PubMed ID: 17049565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNF-alpha -308A promoter polymorphism is associated with enhanced TNF-alpha production and inflammatory activity in Crohn's patients with fistulizing disease.
    González S; Rodrigo L; Martínez-Borra J; López-Vázquez A; Fuentes D; Niño P; Cadahía V; Saro C; Dieguez MA; López-Larrea C
    Am J Gastroenterol; 2003 May; 98(5):1101-6. PubMed ID: 12809834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF promoter polymorphisms and modulation of growth retardation and disease severity in pediatric Crohn's disease.
    Levine A; Shamir R; Wine E; Weiss B; Karban A; Shaoul RR; Reif SS; Yakir B; Friedlander M; Kaniel Y; Leshinsky-Silver E
    Am J Gastroenterol; 2005 Jul; 100(7):1598-604. PubMed ID: 15984988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between a gene polymorphism of tumor necrosis factor and inflammatory bowel disease.
    Song Y; Wu KC; Zhang L; Hao ZM; Li HT; Zhang LX; Qiao TD; Li CN; Fan DM
    Chin J Dig Dis; 2005; 6(4):170-4. PubMed ID: 16246225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of anti-TNF-alpha therapy on spinal bone mineral density in patients with Crohn's disease.
    Pazianas M; Rhim AD; Weinberg AM; Su C; Lichtenstein GR
    Ann N Y Acad Sci; 2006 Apr; 1068():543-56. PubMed ID: 16831950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profile of soluble cytokine receptors in Crohn's disease.
    Gustot T; Lemmers A; Louis E; Nicaise C; Quertinmont E; Belaiche J; Roland S; Van Gossum A; Devière J; Franchimont D
    Gut; 2005 Apr; 54(4):488-95. PubMed ID: 15753533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing complicated Crohn's disease in children and adolescents.
    Homan M; Baldassano RN; Mamula P
    Nat Clin Pract Gastroenterol Hepatol; 2005 Dec; 2(12):572-9. PubMed ID: 16327836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infliximab induced T lymphocyte apoptosis in Crohn's disease.
    van den Brande J; Hommes DW; Peppelenbosch MP
    J Rheumatol Suppl; 2005 Mar; 74():26-30. PubMed ID: 15742461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.